Klaviyo [KVYO] vs Amdocs [DOX] Detailed Stock Comparison
Klaviyo
NYSE
Loading...
Amdocs
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Klaviyo wins in 5 metrics, Amdocs wins in 12 metrics, with 0 ties. Amdocs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Klaviyo | Amdocs | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -179.00 | 17.61 | Klaviyo |
| Price-to-Book Ratio | 8.75 | 2.75 | Amdocs |
| Debt-to-Equity Ratio | 9.04 | 23.65 | Klaviyo |
| PEG Ratio | -0.51 | 1.26 | Klaviyo |
| EV/EBITDA | -96.17 | 10.36 | Klaviyo |
| Profit Margin (TTM) | -6.19% | 11.94% | Amdocs |
| Operating Margin (TTM) | -10.69% | 17.68% | Amdocs |
| EBITDA Margin (TTM) | N/A | 17.68% | N/A |
| Return on Equity | -6.42% | 15.73% | Amdocs |
| Return on Assets (TTM) | -5.05% | 7.79% | Amdocs |
| Free Cash Flow (TTM) | $148.73M | $618.93M | Amdocs |
| 1-Year Return | -2.14% | 1.38% | Amdocs |
| Price-to-Sales Ratio (TTM) | 8.91 | 2.08 | Amdocs |
| Enterprise Value | $8.77B | $10.20B | Amdocs |
| EV/Revenue Ratio | 8.13 | 2.20 | Amdocs |
| Gross Profit Margin (TTM) | 75.70% | 37.86% | Klaviyo |
| Revenue per Share (TTM) | $4 | $41 | Amdocs |
| Earnings per Share (Diluted) | $-0.24 | $4.94 | Amdocs |
| Beta (Stock Volatility) | N/A | 0.52 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Klaviyo vs Amdocs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Klaviyo | 2.27% | 3.06% | -1.63% | -3.12% | -23.58% | -23.20% |
| Amdocs | -0.36% | -0.85% | -1.61% | -5.57% | -1.58% | 2.91% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Klaviyo | -2.14% | -4.22% | -4.22% | -4.22% | -4.22% | -4.22% |
| Amdocs | 1.38% | 0.32% | 42.38% | 50.18% | 228.94% | 204.75% |
Performance & Financial Health Analysis: Klaviyo vs Amdocs
| Metric | KVYO | DOX |
|---|---|---|
| Market Information | ||
| Market Cap | $9.61B | $9.68B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 3,615,530 | 882,546 |
| 90 Day Avg. Volume | 2,018,393 | 784,365 |
| Last Close | $31.98 | $86.61 |
| 52 Week Range | $23.77 - $49.55 | $78.61 - $95.41 |
| % from 52W High | -35.46% | -9.22% |
| All-Time High | $49.55 (Feb 10, 2025) | $99.75 (Jun 26, 2023) |
| % from All-Time High | -35.46% | -13.17% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.32% | -0.08% |
| Quarterly Earnings Growth | 0.32% | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | -0.06% | 0.12% |
| Operating Margin (TTM) | -0.11% | 0.18% |
| Return on Equity (TTM) | -0.06% | 0.16% |
| Debt to Equity (MRQ) | 9.04 | 23.65 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.66 | $31.67 |
| Cash per Share (MRQ) | $3.12 | $3.10 |
| Operating Cash Flow (TTM) | $168.96M | $737.18M |
| Levered Free Cash Flow (TTM) | $186.32M | $554.44M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Klaviyo vs Amdocs
| Metric | KVYO | DOX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -179.00 | 17.61 |
| Forward P/E | 57.18 | 12.38 |
| PEG Ratio | -0.51 | 1.26 |
| Price to Sales (TTM) | 8.91 | 2.08 |
| Price to Book (MRQ) | 8.75 | 2.75 |
| Market Capitalization | ||
| Market Capitalization | $9.61B | $9.68B |
| Enterprise Value | $8.77B | $10.20B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.13 | 2.20 |
| Enterprise to EBITDA | -96.17 | 10.36 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.52 |
| Book Value per Share (MRQ) | $3.66 | $31.67 |
Financial Statements Comparison: Klaviyo vs Amdocs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KVYO | DOX |
|---|---|---|
| Revenue/Sales | $293.12M | $1.13B |
| Cost of Goods Sold | $71.24M | $698.05M |
| Gross Profit | $221.88M | $430.15M |
| Research & Development | $72.46M | $81.80M |
| Operating Income (EBIT) | $-31.33M | $197.74M |
| EBITDA | $-27.40M | $244.14M |
| Pre-Tax Income | $-22.48M | $189.27M |
| Income Tax | $1.80M | $25.27M |
| Net Income (Profit) | $-24.28M | $164.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KVYO | DOX |
|---|---|---|
| Cash & Equivalents | $888.43M | $247.39M |
| Total Current Assets | $1.01B | $1.56B |
| Total Current Liabilities | $192.82M | $1.34B |
| Long-Term Debt | $84.12M | $748.93M |
| Total Shareholders Equity | $1.06B | $3.50B |
| Retained Earnings | $-859.27M | N/A |
| Property, Plant & Equipment | $90.82M | $874.85M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KVYO | DOX |
|---|---|---|
| Operating Cash Flow | $36.85M | $195.07M |
| Capital Expenditures | $-2.69M | $-15.96M |
| Free Cash Flow | $6.62M | $156.49M |
| Debt Repayment | $0 | N/A |
| Common Stock Repurchase | N/A | $-135.24M |
Short Interest & Institutional Ownership Analysis
| Metric | KVYO | DOX |
|---|---|---|
| Shares Short | 5.50M | 4.39M |
| Short Ratio | 4.80 | 6.52 |
| Short % of Float | 0.05% | 0.05% |
| Average Daily Volume (10 Day) | 3,615,530 | 882,546 |
| Average Daily Volume (90 Day) | 2,018,393 | 784,365 |
| Shares Outstanding | 272.76M | 112.89M |
| Float Shares | 4.99M | 108.37M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 1.10% | 0.98% |
Dividend Analysis & Yield Comparison: Klaviyo vs Amdocs
| Metric | KVYO | DOX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |